OTC · PHLI
PacificHealth Laboratories, Inc.
Consumer Defensive · Household & Personal Products
$0.00
Up+$0.00 (+9900.00%)
Updated Aug 16, 2026, 10:20 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 438.31K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1K
- Avg. volume
- 243.9
Price performance
PHLI price history
1M range · 0 trading sessions · Daily adjusted prices
PHLI does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest PHLI news
The latest Smart Investors Daily articles mentioning PHLI.
Stock researchCompany · Overview
PHLI research
Overview
Company profile and research snapshot.
Company profile
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
